BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31746439)

  • 21. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
    Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
    Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis.
    Wu X; Li X; Xu G
    Oncol Rep; 2020 Aug; 44(2):487-498. PubMed ID: 32468043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AURKA Identified as Potential Lung Cancer Marker through Comprehensive Bioinformatic Analysis and Experimental Verification.
    Shi S; Qiu Y; Jin Z; Zhou J; Yu W; Zhang H
    Crit Rev Eukaryot Gene Expr; 2023; 33(5):39-59. PubMed ID: 37199313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
    Wang W; Wang S; Pan L
    Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.
    Chen Y; Liu D; Liu P; Chen Y; Yu H; Zhang Q
    Mol Med Rep; 2017 Mar; 15(3):1051-1056. PubMed ID: 28098904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
    Qin X; Song Y
    Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA‑gene pairs in small‑cell lung cancer.
    Mao Y; Xue P; Li L; Xu P; Cai Y; Chu X; Jiang P; Zhu S
    Mol Med Rep; 2019 Sep; 20(3):2199-2208. PubMed ID: 31257520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of key genes and miRNAs markers of papillary thyroid cancer.
    Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
    Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of MicroRNA-Target Gene-Transcription Factor Regulatory Networks in Colorectal Adenoma Using Microarray Expression Data.
    Gao Y; Zhang S; Zhang Y; Qian J
    Front Genet; 2020; 11():463. PubMed ID: 32508878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of an MiRNA-mRNA Regulatory Network in Colorectal Cancer.
    Cui MF; Wu YY; Chen MY; Zhao Y; Han SY; Wang RJ; Zhang H; Fang XD
    Comb Chem High Throughput Screen; 2021; 24(10):1736-1745. PubMed ID: 33172374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
    Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
    Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
    Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
    Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatic Analysis Identifies of Potential miRNA-mRNA Regulatory Networks Involved in the Pathogenesis of Lung Cancer.
    Hao D; Li Y; Shi J; Jiang J
    Comput Intell Neurosci; 2022; 2022():6295934. PubMed ID: 36211008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of potential biomarkers in the occurrence and development of type 1 diabetes mellitus based on transcriptome analysis.
    Kang J; Shen X; Yang L; Feng S; Li D; Yuan H
    Endokrynol Pol; 2020; 71(1):58-65. PubMed ID: 33140399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.